Multi-Cancer Early Detection Screening Programme
Multi-Cancer Early Detection Screening Programme
The Multi-Cancer Early Detection Test (Test) offered under this “Multi-Cancer Early Detection Screening Programme” (Programme) utilises next generation sequencing (NGS) technology to analyze circulating tumour DNA (ctDNA) in the blood to detect cancer. With just one draw of blood, the Test can enable detection of early signals of common types of cancer.

The Test demonstrates high sensitivity and 99% specificity, helping to identify cancer risks at an early stage and supporting early prevention and diagnosis.*
Scope of Screening
The Test can detect signals associated with up to 50 common and high risk cancers, including:

Lung cancer

Breast cancer

Colorectal cancer

Liver cancer

Pancreatic cancer

Stomach cancer
Who Should Consider The Test
The screening is recommended for:

Individuals aged above 40, non pregnant, with no cancer history in the past 3 – 5 years

Individuals have unhealthy dietary or lifestyle habits

Individuals with a family history of cancer

Individuals who are concerned about cancer risk and wish to undergo preventive screening
Test Options
Three different versions of the Test are available under this Programme, allowing individuals to choose based on their health needs and budget.
Basic Plan
Fee(HKD)
HK$4,800
Core Plan
Fee(HKD)
HK$5,800
Premium Plan
Fee(HKD)
HK$22,800
Advantages of the Test
- Non invasive: requires only a blood draw
- High sensitivity1,2,3: detects early cancer related signals effectively
- High specificity1,2,3: reduces false-positive rates
- Comprehensive:one test covers multiple cancer types

1 Nguyen, L.H.D. et al. Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Med (2025). https://doi.org/10.1186/s12916-025-03929-y
2 Poh, J. et al. J. Clin. Oncol. 2024; 42(16): e15042.
3 Tucker, S. et al. Ann. Oncol. 2023; 34: S1625–S1626
| Cancer Types | Basic Plan6 Cancer TypesHK$4,800 | Core Plan10 Cancer TypesHK$5,800 | Premium Plan50 Cancer TypesHK$22,800 |
|---|---|---|---|
| This programme is applicable to both males and females | |||
| General Health Assessment | |||
| Blood Pressure, Height, Weight and Body Mass Index | ✓ | ✓ | ✓ |
| Multi-Cancer Screening | |||
| Lung Cancer | ✓ | ✓ | ✓ |
| Lung Neuroendocrine Tumour | — | — | ✓ |
| Breast Cancer | ✓ | ✓ | ✓ |
| Nasopharyngeal Cancer (EBV+) | — | — | ✓ |
| Laryngeal Cancer | — | — | ✓ |
| Oropharyngeal Cancer (HPV+) | — | — | ✓ |
| Oropharyngeal Cancer (HPV-) | — | — | ✓ |
| Salivary Gland Cancer | — | — | ✓ |
| Prostate Cancer | — | — | ✓ |
| Adrenal Cancer | — | — | ✓ |
| Adult Wilms Tumour | — | — | ✓ |
| Bladder Cancer | — | — | ✓ |
| Kidney Cancer (Clear Cell) | — | — | ✓ |
| Penile Cancer | — | — | ✓ |
| Testicular Cancer | — | — | ✓ |
| Pancreatic Cancer | ✓ | ✓ | ✓ |
| Bile Duct Cancer (Intrahepatic) | — | — | ✓ |
| Bile Duct Cancer (Extrahepatic) | — | — | ✓ |
| Gallbladder Cancer | — | — | ✓ |
| Liver Cancer | ✓ | — | ✓ |
| Colorectal Cancer | ✓ | ✓ | ✓ |
| Colorectal Neuroendocrine Tumour | — | — | ✓ |
| Gastrointestinal Stromal Tumour | — | — | ✓ |
| Stomach Cancer | — | ✓ | ✓ |
| Stomach Neuroendocrine Tumour | — | — | ✓ |
| Esophageal Cancer | — | ✓ | ✓ |
| Small Intestine Cancer | — | — | ✓ |
| Cervical Cancer | — | — | ✓ |
| Endometrial Cancer | — | ✓ | ✓ |
| Ovarian Cancer | — | ✓ | ✓ |
| Vulvar Cancer | — | — | ✓ |
| Ovarian Germ Cell & Stromal Tumour | — | — | ✓ |
| Acute Myeloid Leukemia (NPM1-mutated) | — | — | ✓ |
| Acute Myeloid Leukemia (Other Defined Genetic Alterations) | — | — | ✓ |
| Acute Myeloid Leukemia (Myelodysplasia-Related) | — | — | ✓ |
| Mast Cell Tumour | — | — | ✓ |
| Myeloproliferative Neoplasm | — | — | ✓ |
| Myeloma | — | — | ✓ |
| Burkitt's Lymphoma | — | — | ✓ |
| Diffuse Large B-cell Lymphoma | — | — | ✓ |
| Hairy Cell Leukemia | — | — | ✓ |
| Lymphoplasmacytic Lymphoma | — | — | ✓ |
| Conjunctival Melanoma | — | — | ✓ |
| Uveal Melanoma | — | — | ✓ |
| Skin Cancer (Non-melanoma) | — | — | ✓ |
| Skin Cancer (Melanoma) | — | — | ✓ |
| Thyroid Cancer | ✓ | — | ✓ |
| Bone Cancer | — | — | ✓ |
| Sarcoma (Angiosarcoma) | — | — | ✓ |
| Sarcoma (Smooth Muscle) | — | — | ✓ |
| Head & Neck Cancer | — | ✓ | ✓Already covered in items above |
| Liver and Bile Duct Cancer | — | ✓ | ✓Already covered in items above |
| Report Analysis | |||
| Report Analysis (Pre- and post-test doctor's consultation) | ✓ | ✓ | ✓ |
| Fee (HKD) | HK$4,800Book Now | HK$5,800Book Now | HK$22,800Book Now |
* Price is inclusive of pre- and post-test doctor's consultation
CUHK Medical Clinic
(Tsim Sha Tsui)
3468 7141
Sat 9:30AM – 1:30PM
CUHK Medical Clinic
(Sai Sha)
3946 6046
Sat 3:00PM – 7:00PM
Important Notes
- The pre-test and post-test doctor’s consultation under this Programme will be conducted by doctor(s) designated by CUHK Medical Centre / CUHK Medical Clinic.
- Except for the pre-test and post-test doctor’s consultation, the prices under this Programme do not include specialist consultation fees, treatment fees, medication charges, etc.
- This Programme requires advance appointment.
- If the doctor determines that you are not suitable to receive the services under this Programme, or this Programme is not applicable to you, CUHK Medical Centre / CUHK Medical Clinic will only charge doctor’s consultation fee and (if applicable) any related diagnostic and/or medication fees/charges according to its/their prevailing prices.
- In the event that you are unable to complete all items under this Programme for any reason, CUHK Medical Centre / CUHK Medical Clinic reserves the right to charge for the item(s) already completed according to its/their prevailing prices.
- This Programme is only applicable to individuals aged 18 or above.
- Unless otherwise specified by CUHK Medical Centre / CUHK Medical Clinic, no promotional offer or discount is applicable to this Programme.
- This Programme is only applicable to self-paying clients; direct billing is not applicable.
- In case of any dispute, the decision of CUHK Medical Centre Limited and/or CUHK Medical Clinic Limited (as the case may be) shall be final and conclusive.


